Grantham, Mayo, Van Otterloo & Co (GMO)
HUM icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Humana HUM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.79M Buy
44,950
+9,654
+27% +$1.98M 0.02% 270
2025
Q4 		$9.04M Sell
35,296
-6,924
-16% -$1.82M 0.02% 246
2025
Q3 		$11M Sell
42,220
-5,174
-11% -$1.36M 0.03% 230
2025
Q2 		$11.6M Buy
47,394
+591
+1% +$147K 0.03% 220
2025
Q1 		$12.4M Buy
46,803
+6,438
+16% +$1.74M 0.04% 218
2024
Q4 		$10.2M Buy
40,365
+23,853
+144% +$6.4M 0.03% 251
2024
Q3 		$5.23M Sell
16,512
-37,287
-69% -$13.3M 0.02% 323
2024
Q2 		$20.1M Buy
53,799
+4,524
+9% +$1.53M 0.07% 196
2024
Q1 		$17.1M Buy
49,275
+16,837
+52% +$6.38M 0.06% 206
2023
Q4 		$14.9M Buy
32,438
+2,955
+10% +$1.46M 0.07% 205
2023
Q3 		$14.3M Buy
29,483
+22,760
+339% +$10.7M 0.07% 221
2023
Q2 		$3.01M Sell
6,723
-877
-12% -$442K 0.01% 395
2023
Q1 		$3.69M Sell
7,600
-4,200
-36% -$2.08M 0.02% 357
2022
Q4 		$6.04M Sell
11,800
-2,500
-17% -$1.31M 0.03% 307
2022
Q3 		$6.94M Buy
14,300
+11,900
+496% +$5.79M 0.04% 290
2022
Q2 		$1.12M Buy
+2,400
New +$1.07M 0.01% 506
2020
Q2 		– Sell
-74,585
Closed -$23.4M – 790
2020
Q1 		$23.4M Sell
74,585
-285,920
-79% -$96.4M 0.2% 78
2019
Q4 		$132M Buy
+360,505
New +$114M 0.88% 29
2019
Q2 		– Sell
-27,700
Closed -$7.37M – 733
2019
Q1 		$7.37M Buy
27,700
+3,100
+13% +$893K 0.05% 215
2018
Q4 		$7.05M Buy
+24,600
New +$7.8M 0.06% 162
2018
Q2 		– Sell
-171,615
Closed -$46.1M – 575
2018
Q1 		$46.1M Sell
171,615
-321,636
-65% -$87.1M 0.28% 65
2017
Q4 		$122M Sell
493,251
-38,424
-7% -$9.49M 0.72% 42
2017
Q3 		$130M Sell
531,675
-37,434
-7% -$9.17M 0.76% 40
2017
Q2 		$137M Buy
569,109
+137,248
+32% +$31.1M 0.76% 33
2017
Q1 		$89M Sell
431,861
-131,453
-23% -$27.2M 0.5% 51
2016
Q4 		$115M Sell
563,314
-86,223
-13% -$16.4M 0.62% 36
2016
Q3 		$115M Sell
649,537
-6,245
-1% -$1.08M 0.54% 39
2016
Q2 		$118M Sell
655,782
-87,597
-12% -$15.6M 0.48% 48
2016
Q1 		$136M Sell
743,379
-385,300
-34% -$66.8M 0.51% 49
2015
Q4 		$201M Sell
1,128,679
-238,693
-17% -$41.9M 0.72% 37
2015
Q3 		$245M Buy
1,367,372
+431,607
+46% +$79.8M 0.85% 26
2015
Q2 		$179M Sell
935,765
-38,300
-4% -$7.11M 0.58% 41
2015
Q1 		$173M Sell
974,065
-132,889
-12% -$21M 0.52% 45
2014
Q4 		$159M Sell
1,106,954
-18,999
-2% -$2.6M 0.43% 49
2014
Q3 		$147M Buy
1,125,953
+100,996
+10% +$12.8M 0.39% 52
2014
Q2 		$131M Buy
1,024,957
+120,400
+13% +$14.3M 0.36% 54
2014
Q1 		$102M Buy
904,557
+732,273
+425% +$76.3M 0.27% 64
2013
Q4 		$17.8M Buy
172,284
+32,180
+23% +$3.15M 0.04% 158
2013
Q3 		$13.1M Buy
140,104
+5,565
+4% +$511K 0.03% 182
2013
Q2 		$11.4M Buy
+134,539
New +$10.6M 0.03% 193

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HUM Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Humana (HUM) stake by 27% in Q1 2026, buying an estimated $1.98M and bringing the position to 44,950 shares worth $7.79M. The position accounts for 0.02% of the portfolio, ranked #270.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HUM in Q2 2013 and has held it in 40 quarters since. The position peaked at $245M in Q3 2015. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 44,950 shares of Humana worth $7.79M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 9,654 Humana shares in Q1 2026, an estimated $1.98M.
  • Humana made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #270 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Humana in Q2 2013 and has held it in 40 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Humana position peaked at $245M in Q3 2015.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.